Europe Glycomics Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Glycomics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Glycomics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in demand for high-quality oligosaccharides
5.1.2 Rise in research on glycan profiling

5.2 Market Opportunities

5.2.1 Growth in glycomics research and diagnostics
5.2.2 Expansion in biopharmaceutical applications

5.3 Future Trends

5.3.1 Increase in glycomic profiling applications
5.3.2 Growth in therapeutic glycomics research

5.4 Impact of Drivers and Restraints

6. Europe Glycomics Market Regional Analysis

6.1 Europe Glycomics Market Overview

6.2 Europe Glycomics Market Revenue 2020-2028 (US$ Million)

6.3 Europe Glycomics Market Forecast Analysis

7. Europe Glycomics Market Analysis – by Product

7.1 Enzymes

7.1.1 Overview
7.1.2 Enzymes: Europe Glycomics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: Europe Glycomics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Kits

7.3.1 Overview
7.3.2 Kits: Europe Glycomics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Reagents

7.4.1 Overview
7.4.2 Reagents: Europe Glycomics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Glycomics Market Analysis – by Application

8.1 Drug Discovery and Development

8.1.1 Overview
8.1.2 Drug Discovery and Development: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Diagnostics

8.2.1 Overview
8.2.2 Diagnostics: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Immunology

8.3.1 Overview
8.3.2 Immunology: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cancer

8.4.1 Overview
8.4.2 Cancer: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Glycomics Market Analysis – by End User

9.1 Pharmaceutical & Biotechnology Companies

9.1.1 Overview
9.1.2 Cancer: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Academic & Research Institutes

9.2.1 Overview
9.2.2 Cancer: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Contract Research Organizations

9.3.1 Overview
9.3.2 Cancer: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Glycomics Market – Europe Analysis

10.1 Europe

10.1.1 Europe Glycomics Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 Europe Glycomics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Glycomics Market Breakdown, by Product
10.1.1.1.2 UK: Europe Glycomics Market Breakdown, by Application
10.1.1.1.3 UK: Europe Glycomics Market Breakdown, by End User

10.1.1.2 Germany: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Glycomics Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Glycomics Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Glycomics Market Breakdown, by End User

10.1.1.3 France: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Glycomics Market Breakdown, by Product
10.1.1.3.2 France: Europe Glycomics Market Breakdown, by Application
10.1.1.3.3 France: Europe Glycomics Market Breakdown, by End User

10.1.1.4 Russia: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Glycomics Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Glycomics Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Glycomics Market Breakdown, by End User

10.1.1.5 Italy: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Glycomics Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Glycomics Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Glycomics Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Glycomics Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Glycomics Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Glycomics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Glycomics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Asparia Glycomics

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bruker Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 MERCK KGaA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 New England Biolabs

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 S-BIO (Sumitomo Bakelite Co., Ltd.)

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Shimadzu Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Takara Bio Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Waters Corporation

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights